B7-1 and PlGF-1 are two possible new biomarkers to identify fracture-associated trauma patients at higher risk of developing complications: a cohort study.
Alcohol consumption
B7-1
Complication
Fracture repair
Gender
Obesity
PlGF-1
Trauma
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
29 Aug 2024
29 Aug 2024
Historique:
received:
22
11
2023
accepted:
16
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Around 10% of fractures lead to complications. With increasing fracture incidences in recent years, this poses a serious burden on the healthcare system, with increasing costs for treatment. In the present study, we aimed to identify potential 'new' blood markers to predict the development of post-surgical complications in trauma patients following a fracture. A total of 292 trauma patients with a complete three-month follow-up were included in this cohort study. Blood samples were obtained from 244 of these patients. Two complication groups were distinguished based on the Clavien-Dindo (CD) classification: CD grade I and CD grade III groups were compared to the controls (CD 0). The Mann-Whitney U test was used to compare the complication groups to the control group. Analysis of the patients' data revealed that risk factors are dependent on sex. Both, males and females who developed a CD III complication showed elevated blood levels of B7-1 (p = 0.015 and p = 0.018, respectively) and PlGF-1 (p = 0.009 and p = 0.031, respectively), with B7-1 demonstrating greater sensitivity (B7-1: 0.706 (male) and 0.692 (female), PlGF-1: 0.647 (male) and 0.615 (female)). Further analysis of the questionnaires and medical data revealed the importance of additional risk factors. For males (CD 0: 133; CD I: 12; CD III: 18 patients) alcohol consumption was significantly increased for CD I and CD III compared to control with p = 0.009 and p = 0.007, respectively. For females (CD 0: 107; CD I: 10; CD III: 12 patients) a significantly increased average BMI [kg/m These two potential new blood markers hold promise for predicting complication development in trauma patients. Nevertheless, further studies are necessary to evaluate the diagnostic utility of B7-1 and PlGF-1 in predicting complications in trauma patients and consider sex differences before their possible use as routine clinical screening tools.
Sections du résumé
BACKGROUND
BACKGROUND
Around 10% of fractures lead to complications. With increasing fracture incidences in recent years, this poses a serious burden on the healthcare system, with increasing costs for treatment. In the present study, we aimed to identify potential 'new' blood markers to predict the development of post-surgical complications in trauma patients following a fracture.
METHODS
METHODS
A total of 292 trauma patients with a complete three-month follow-up were included in this cohort study. Blood samples were obtained from 244 of these patients. Two complication groups were distinguished based on the Clavien-Dindo (CD) classification: CD grade I and CD grade III groups were compared to the controls (CD 0). The Mann-Whitney U test was used to compare the complication groups to the control group.
RESULTS
RESULTS
Analysis of the patients' data revealed that risk factors are dependent on sex. Both, males and females who developed a CD III complication showed elevated blood levels of B7-1 (p = 0.015 and p = 0.018, respectively) and PlGF-1 (p = 0.009 and p = 0.031, respectively), with B7-1 demonstrating greater sensitivity (B7-1: 0.706 (male) and 0.692 (female), PlGF-1: 0.647 (male) and 0.615 (female)). Further analysis of the questionnaires and medical data revealed the importance of additional risk factors. For males (CD 0: 133; CD I: 12; CD III: 18 patients) alcohol consumption was significantly increased for CD I and CD III compared to control with p = 0.009 and p = 0.007, respectively. For females (CD 0: 107; CD I: 10; CD III: 12 patients) a significantly increased average BMI [kg/m
CONCLUSIONS
CONCLUSIONS
These two potential new blood markers hold promise for predicting complication development in trauma patients. Nevertheless, further studies are necessary to evaluate the diagnostic utility of B7-1 and PlGF-1 in predicting complications in trauma patients and consider sex differences before their possible use as routine clinical screening tools.
Identifiants
pubmed: 39210389
doi: 10.1186/s12891-024-07789-0
pii: 10.1186/s12891-024-07789-0
pmc: PMC11360573
doi:
Substances chimiques
Biomarkers
0
Placenta Growth Factor
144589-93-5
PGF protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
677Informations de copyright
© 2024. The Author(s).
Références
Injury. 2018 Feb;49(2):177-183
pubmed: 29162268
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
Ann Surg. 2010 Feb;251(2):195-200
pubmed: 20054269
Biomedicines. 2024 Feb 02;12(2):
pubmed: 38397956
J Cell Biochem. 2003 Apr 1;88(5):873-84
pubmed: 12616527
PLoS One. 2009 Aug 12;4(8):e6600
pubmed: 19672303
J Shoulder Elbow Surg. 2017 Jan;26(1):1-6
pubmed: 27810265
Am J Epidemiol. 2007 Sep 1;166(5):495-505
pubmed: 17575306
J Bone Joint Surg Am. 2011 Sep 7;93(17):1577-82
pubmed: 21915571
Bone Rep. 2023 Nov 10;19:101723
pubmed: 38047271
Wound Repair Regen. 2019 May;27(3):249-256
pubmed: 30663823
Am J Surg. 2018 Apr;215(4):651-657
pubmed: 28982517
Nitric Oxide. 2009 Jun;20(4):298-303
pubmed: 19281856
Age Ageing. 2014 Mar;43(2):234-40
pubmed: 24231585
Brain Behav Immun. 2015 May;46:87-95
pubmed: 25557189
Iowa Orthop J. 2006;26:17-26
pubmed: 16789443
J Immunol. 1998 Feb 15;160(4):1831-40
pubmed: 9469444
J Bone Miner Res. 2002 Mar;17(3):513-20
pubmed: 11874242
Injury. 2006 Jun;37(6):475-84
pubmed: 16118010
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15569-74
pubmed: 16221763
JAMA Surg. 2016 Nov 16;151(11):e162775
pubmed: 27603155
J Am Acad Orthop Surg. 2000 Jul-Aug;8(4):253-65
pubmed: 10951114
Injury. 2011 Jun;42(6):551-5
pubmed: 21489527
Int J Mol Sci. 2018 Aug 07;19(8):
pubmed: 30087255
Immunol Lett. 2011 Dec 30;141(1):28-35
pubmed: 21911007
Diabetes Metab Syndr Obes. 2014 Dec 04;7:587-91
pubmed: 25506234
Clin Chem Lab Med. 2013 Apr;51(4):713-27
pubmed: 23515103
Genes Immun. 2011 Dec;12(8):595-604
pubmed: 22048452
Curr Osteoporos Rep. 2018 Apr;16(2):138-145
pubmed: 29508143
J Orthop Trauma. 2010 Sep;24(9):522-5
pubmed: 20736786
Clin Cases Miner Bone Metab. 2014 Jan;11(1):9-14
pubmed: 25002873
Int Immunol. 2006 Mar;18(3):473-84
pubmed: 16481347
J Biol Chem. 1996 Oct 25;271(43):26762-71
pubmed: 8900156
Eur Respir J. 2014 Oct;44(4):1055-68
pubmed: 25142482
Cureus. 2022 Nov 1;14(11):e30975
pubmed: 36465229
BMC Cancer. 2022 Apr 7;22(1):370
pubmed: 35392845
Cells. 2014 Oct 15;3(4):981-93
pubmed: 25317929
Front Immunol. 2020 Aug 26;11:2081
pubmed: 32983160
JAMA Netw Open. 2020 Jun 1;3(6):e208958
pubmed: 32584409
Health Serv Manage Res. 2017 May;30(2):105-120
pubmed: 28539083
J Orthop Res. 2010 Jun;28(6):778-84
pubmed: 20041490
Acta Orthop. 2018 Oct;89(5):585-590
pubmed: 30080430
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Sep;57(9):1022-30
pubmed: 25030232
Dtsch Arztebl Int. 2022 Sep 30;119(39):651-657
pubmed: 35915922
Osteoporos Int. 2012 Sep;23(9):2239-56
pubmed: 22419370
Ann Intern Med. 2001 Apr 17;134(8):637-43
pubmed: 11304103
Dtsch Arztebl Int. 2021 Oct 8;118(40):665-669
pubmed: 34140088
Nat Rev Rheumatol. 2012 Jan 31;8(3):133-43
pubmed: 22293759
Nat Rev Rheumatol. 2015 Jan;11(1):45-54
pubmed: 25266456
J Int Med Res. 2017 Apr;45(2):691-705
pubmed: 28173723
J Clin Invest. 2006 May;116(5):1230-42
pubmed: 16614757
Internist (Berl). 2017 Apr;58(4):336-343
pubmed: 28289763
Acta Orthop. 2012 Dec;83(6):653-60
pubmed: 23140093
Int J Environ Res Public Health. 2018 Dec 13;15(12):
pubmed: 30551632
Adv Wound Care (New Rochelle). 2013 Jun;2(5):215-224
pubmed: 24527344
PLoS One. 2020 Dec 21;15(12):e0244291
pubmed: 33347485
J Bone Miner Res. 2014 Mar;29(3):581-9
pubmed: 23959594
PLoS One. 2018 Nov 8;13(11):e0207203
pubmed: 30408118
J Immunol Res. 2016;2016:8605134
pubmed: 27413764
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Semin Immunol. 2013 Dec 15;25(6):469-84
pubmed: 24275598
J Clin Med. 2019 Mar 24;8(3):
pubmed: 30909629
Drug Alcohol Depend. 2013 Oct 1;132(3):521-7
pubmed: 23683792
BMJ. 2005 Dec 10;331(7529):1374
pubmed: 16299013
J Clin Endocrinol Metab. 2013 Jun;98(6):2478-83
pubmed: 23559081
Sci Transl Med. 2014 May 7;6(235):235ra60
pubmed: 24807557
J Exp Med. 1991 Mar 1;173(3):721-30
pubmed: 1847722
Bone Rep. 2021 Dec 09;16:101157
pubmed: 34950754
J Gen Intern Med. 2011 Feb;26(2):162-9
pubmed: 20878363
Int J Mol Sci. 2020 Oct 14;21(20):
pubmed: 33066607
Ann Surg. 2020 Jan;271(1):23-28
pubmed: 30601252